Investor Relations

Press Releases

July 1, 2026

Press Release: Availability of the aide-mémoire for Q2 2026 results

June 30, 2026

Press Release: Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study

Read the Press Release

June 25, 2026

Press Release: Sanofi Foundation opens new chapter centered on future generations

Read the Press Release

See more press releases

Upcoming Events

30Jul

2026

Second quarter 2026 results

Second quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on July 30, 2026. The presentation will be followed by a Q&A session.

13:00 - 14:15 CET (7:00am - 8:15am EDT)

Quarterly results

Discover more

9Sep

2026

Kepler Cheuvreux Autumn Conference l Paris

Speaker : Thomas Grenier, Head of North America, Vaccines

Conferences

30Oct

2026

Third quarter 2026 results

Third quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on October 30, 2026. The presentation will be followed by a Q&A session.

13:00 - 14:00 CET (7:00am - 8:00am EDT)

Quarterly results

All our events

Female scientist in white lab coat and safety equipment working with a tablet at a laboratory workstation with protective hood

Shuang Yang, Scientist, China

2025 20-F

Presenting our 2025 FORM 20-F.

31st Consecutive Year of Dividend Increase

Learn more

Dr. Yohana Mokiwa has a serious expression, blue shirt and stethoscope, as he speaks with a patient in a pop up clinic

Dr. Yohana Mokiwa speaking with a patient in a pop-up clinic, Dar es Salaam, Tanzania

Environment, Social, Governance

As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.